ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

4-Toluenesulfonyl chloride → [5-(5-Ethyl-6-methoxy-2-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-ylmethyl]-carbamic acid tert-butyl ester

HRID 1921377
印刷

反応式

HRID 1921377 の反応式
[C:1]([O:5][C:6](=[O:25])[NH:7][CH2:8][C:9]([NH:11][NH:12][C:13]([C:15]1[CH:20]=[C:19]([CH2:21][CH3:22])[C:18](=[O:23])[NH:17][C:16]=1[CH3:24])=[O:14])=O)([CH3:4])([CH3:3])[CH3:2].S(Cl)([C:29]1C=CC(C)=CC=1)(=O)=O.C(N=P1(N(CC)CC)N(C)CCCN1C)(C)(C)C>O1CCCC1>[C:1]([O:5][C:6](=[O:25])[NH:7][CH2:8][C:9]1[O:14][C:13]([C:15]2[C:16]([CH3:24])=[N:17][C:18]([O:23][CH3:29])=[C:19]([CH2:21][CH3:22])[CH:20]=2)=[N:12][N:11]=1)([CH3:4])([CH3:3])[CH3:2]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 73974-Toluenesulfonyl chlorideHCID 35138512-((1,1-Dimethylethyl)imino)-N,N-diethylhexahydro-1,3-dimethyl-2lambda5-1,3,2-diazaphosphorin-2-amineHCID 67492289{2-[N'-(5-ethyl-2-methyl-6-oxo-1,6-dihydro-pyridine-3-carbonyl)-hydrazino]-2-oxo-ethyl}-carbamic acid tert-butyl ester

生成物 1

HCID 67492424[5-(5-Ethyl-6-methoxy-2-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-ylmethyl]-carbamic acid tert-butyl ester収率 182%

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

反応条件

温度
145 °C

実験手順

Into each of three microwave vials is added {2-[N′-(5-ethyl-2-methyl-6-oxo-1,6-dihydro-pyridine-3-carbonyl)-hydrazino]-2-oxo-ethyl}-carbamic acid tert-butyl ester (190 mg, 0.519 mmol), tosyl chloride (119 mg, 0.624 mmol), and 2-t-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine on polystyrene (2.2 mmol/g, 1.18 g, 2.6 mmol) and anhydrous tetrahydrofuran (6 mL). Each vial is flushed with nitrogen, sealed and heated in the CEM Discover microwave at 145° C. holding at that temperature for 3 min, with a maximum pressure of 7.3 bar. LC/MS shows the reaction is complete. The product from all three vials are filtered and washed with THF. The filtrate is evaporated, and the residue is purified by flash chromatography on a 5-gram silica gel cartridge by elution with dichloromethane:ethyl acetate (3:1). Fractions containing the product are combined again and evaporated to give [5-(5-ethyl-6-methoxy-2-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-ylmethyl]-carbamic acid tert-butyl ester (329 mg, 61% yield). MS: m/e 719 (95%) (2M+Na), 249 (100%) (M+H); 1H NMR (CDCl3, δ, ppm): 7.87 (1H, s), 5.15 (1H, br.), 4.61 (2H, br.d), 4.00 (3H, s), 2.79 (3H, s), 2.60 (2H, q), 1.49 (9H, s), 1.21 (3H, t).

後処理

  1. customEach vial is flushed with nitrogen
  2. customsealed
  3. filtrationThe product from all three vials are filtered
  4. washwashed with THF
  5. customThe filtrate is evaporated
  6. customthe residue is purified by flash chromatography on a 5-gram silica gel cartridge by elution with dichloromethane:ethyl acetate (3:1)
  7. additionFractions containing the product
  8. customevaporated

出典と根拠

ORDレコード
ord-ef2f4218ab4c452e903911df716eb4d3
出典データセット
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08173682B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート